Your session is about to expire
← Back to Search
Online CBT Workshop for Postpartum Depression
Study Summary
This trial will test if an online CBT-workshop helps reduce rates of PPD when added to usual treatment. (n=410)
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with major depressive disorder before.I am 18 years old or older.
- Group 1: Online 1-Day CBT-Based Workshop
- Group 2: Treatment as Usual
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for participants in this medical experiment?
"The clinical trial is actively recruiting subjects, as stated on the official website. This study was first announced on November 10th 2022 and has been modified most recently February 22nd 2023."
What is the sample size for this research project?
"Yes, the information hosted by clinicaltrials.gov affirms that this experiment is open to recruitment. After initially being posted on November 10th 2022 and subsequently edited in February 22nd 2023, 410 individuals are sought from a single site for participation."
What are the desired outcomes of this research endeavor?
"The primary aim of this clinical trial, which will be assessed over a 1, 2, and 3 month period after delivery is determining the presence or absence of major depressive episodes according to Edinburgh Postnatal Depression Scale (EPDS). Secondary objectives include evaluating Quality-Adjusted Life Year (QALY) with EQ-5D-5L's Canadian scoring algorithm for health utility at baseline and one, two and three months postpartum; Generalized Anxiety Disorder diagnosis using MINI International Neuropsychiatric Interview (MINI)'s module; as well as measuring severity through Generalized Anxiety Disorder 7 Item Scale (GAD–7), using"
Share this study with friends
Copy Link
Messenger